Healthcare provision

European regulator finds at least 20 medicines with significant nitrosamine contamination

Exclusive: The European Medicines Agency has said products identified as containing nitrosamine above acceptable levels will likely require a variation in their marketing authorisation.…

James Davies: ‘We have a big vision that has to be turned into reality’

The Royal Pharmaceutical Society's new director for England shares his priorities for 2023 and the Society's plans for supporting the profession.…

Review of homecare medicines service to launch in Scotland

The British Society for Rheumatology first raised concerns about homecare medicines delivery services in 2022 after reports of patients experiencing delays in receiving medicines.…

Understanding the pharmacy workforce

The pick of the latest academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…

Pharmacy prescribing service expected to launch in north west England from July 2023

Exclusive: NHS Lancashire and South Cumbria Integrated Care Board hopes to launch a pharmacy independent prescribing pilot service in the summer of 2023.…

Lessons community pharmacy could learn from the junior doctors’ strike

The Pharmaceutical Journal's health policy columnist considers what pharmacists can take from the junior doctors' approach to industrial action.…

Switching patients from IV to oral antimicrobials

IV antimicrobials are important for the effective treatment of infection but there are many benefits to timely switching to oral formulations. This article explains why switching is important, when switches should be considered and how to improve implementation.…

‘A global outlier’: how drug firms are fighting back against UK tax increases

With the UK tax on net sales of branded medicines quadrupling over the past three years, medicine manufacturers warn it will affect access to new drugs and are threatening to withdraw — but are these empty threats?…

Levy hike puts future of UK-based clinical trials in doubt, says Sanofi chief executive

Exclusive: Jessamy Baird says the rise in the 'Voluntary scheme for branded medicines pricing and access' rate has changed the way decisions are made in research and development.…

‘If you want to influence change, get involved’: why members should stand for RPS pharmacy board election

Current board members explain why Royal Pharmaceutical Society members should stand for election.…